Cargando…
A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)
PURPOSE: We report our experience with the use of the matrix regenerating agent (RGTA) Cacicol(®) after reverse transepithelial all-surface laser ablation (ASLA)-SCHWIND to assess the safety, efficacy, pain, and epithelial healing. METHODS: Forty eyes of 20 myopic patients were prospectively recruit...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404873/ https://www.ncbi.nlm.nih.gov/pubmed/25931809 http://dx.doi.org/10.2147/OPTH.S81061 |